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Abstract
Background/Aims—This in vitro study compared the remineralization effect on white spot 
lesions of casein phosphopeptide-amorphous calcium phosphate crème, or CPP-ACP (MI 
Paste™), 1.1% NaF dentifrice containing 5000 ppm of fluoride (ControlRX™), or CPP-ACP 
crème with 900 ppm of fluoride (MI Paste Plus™) with that of a control.
Methods—Artificial white spot lesions were created on smooth enamel surfaces of sound molars 
using a previously reported demineralization model. Specimens were randomly assigned to four 
treatments (n=35) with a pH-cycling model over 30 days: Control (no treatment); MI Paste (10% 
CPP-ACP crème); F5000 (1.1% NaF dentifrice); or MI Paste Plus (10% CPP-ACP plus 900 ppm 
fluoride crème). Products were applied following manufacturers’ directions. Changes in mean 
lesion depth expressed by percent fluorescence loss (∆F%), and lesion area (mm2) from baseline 
to after treatment were measured with light-induced fluorescence (QLF). Mean values of each 
parameter were compared between groups (p<0.05).
Results—The remineralization pattern for the F5000 group was unique with marked initial 
remineralization during the first 10 days and little subsequent change. Based on mean lesion area, 
the F5000 demonstrated greater remineralization than Control, MI Paste and MI Paste Plus groups. 
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Based on mean fluorescence loss, the F5000 group showed improved remineralization relative to 
MI Paste Plus, but did not differ statistically from the Control at the end of 30 days.
Conclusions—The 1.1% NaF dentifrice demonstrated overall greater remineralization ability 
than 10% CPP-ACP crème. However, the 1.1% NaF dentifrice was only as effective as the Control 
to reduce fluorescence loss.
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INTRODUCTION
Dental caries is a multifactorial disease that results from an imbalance between pathological 
and protective factors. Cariogenic bacteria, fermentable carbohydrates, and salivary 
dysfunction are scientifically accepted as important pathological factors. The imbalance 
produced will result in a rupture of the physiological processes of remineralization and 
demineralization of the dental structure, favoring the latter.1 Consequently, dental caries 
management should also be concentrated on an understanding of the role of remineralization 
in preventing caries progression and reestablishing a healthy balance when demineralization 
occurs.2–4 Whole human saliva has calcium and phosphate ions in supersaturated state and 
therefore the potential to remineralize enamel.5 However, if acid challenges overcome this 
physiological remineralization process, alternative therapeutic approaches are necessary to 
enhance remineralization.
Fluoride is a widely recognized remineralizing agent, interacting with oral fluids on the 
enamel surface and subsurface, and combining with calcium and phosphate ions to form 
carbonate substituted hydroxyapatite and fluorapatite.6 When used in excess during tooth 
development, this element can cause dental fluorosis, and can be toxic if administered in 
high enough doses.7, 8
The possible cariostatic potential of dairy products has been reported by several authors.9–11 
In 1991, the casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) complex, 
derived from a milk protein called casein, was patented in the United States.12 CPP-ACP is 
presented as an alternative remineralizing agent, capable of stabilizing calcium phosphate, 
maintaining a state of supersaturation of these ions in the oral environment. As a 
consequence, the tooth structure would benefit from the high levels of calcium phosphate in 
the biofilm, and remineralization would occur.13, 14 Although products containing CPP-ACP 
are commercially available, there is a lack of consensus regarding its remineralizing 
potential.15–19
The technology to detect and quantitative and qualitatively evaluate carious lesions in vitro 
has greatly evolved. Traditional methods of analysis such as histology, transverse 
microradiography, and polarized light microscopy are effective but destructive and 
inherently time consuming. The use of a quantitative light fluorescence (QLF) to evaluate 
changes before and after remineralization of artificial enamel lesions has been 
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validated.20–22 This technique is non-destructive and performs analysis based on principles 
of light transmission, absorption, scattering.
The aim of this study was to measure the remineralizing effect of a topical tooth crème 
containing CPP-ACP, a fluoride containing dentifrice with 5000 ppm of fluoride, and a 
hybrid topical tooth crème containing CPP-ACP and 900 ppm of fluoride, using a QLF 
technique, on white spot lesions (WSL) in vitro.
MATERIALS AND METHODS
Specimen preparation
Thirty five extracted human third molars were collected from the Department of Oral & 
Maxillofacial Surgery, with approval from the Office of Human Research Ethics of the 
University of North Carolina (#09-1662), over a period of a month and refrigerated and 
hydrated in thymol 0.01% until specimen preparation. Teeth with fluorosis, enamel or dentin 
defects, or presenting any type of dental restoration or sealant were excluded.
The specimens were de-coronated and the crowns sectioned twice, splitting each tooth in 4 
sections of approximately equal size, and providing a total of 140 enamel slabs. Each section 
of the same tooth was identified with the number of the corresponding tooth (1 to 35), as 
well as the location within the tooth structure (mesiofacial, mesiolingual, distofacial, and 
distolingual). This enabled each tooth to serve as its own control, reducing the effects of 
confounders related to inherent differences in the structure and composition of individual 
teeth.23 The enamel surfaces were protected with a polyvinyl siloxane material (Affinity, 
Clinician’s Choice, New Milford, CT), and all specimens were mounted in phenolic rings 
(Buehler, Lake Bluff, IL) with epoxy resin (Buehler). The aprismatic layer of enamel was 
removed from all specimens using an Ecomet Grinder-Polisher machine (Buehler). The 
thickness of each specimen was measured with a digital caliper to provide an initial 
reference. All specimens were flat-polished with water-cooled abrasive papers up to 1200-
grit. During this process, the specimens were constantly measured to verify the amount of 
tooth structure removed, which was always around 100 µm.
To ensure that the demineralizing solution would contact only the polished enamel surface, 
all specimens were covered with a color-free acid-resistant nail varnish (Revlon Nail 
Enamel, Oxford, NC) using a brush under microscope. All surfaces were coated except for 
the flat-ground enamel area after which the specimens were subjected to demineralization.
Lesion creation (demineralization)
The demineralizing medium consisted of 15% G8 Gel (Fisher Scientific, Pittsburgh, PA), 0.1 
m lactic acid-sodium lactate (Sigma-Aldrich, St. Louis, MO), and 1 ppm NaF (Fisher 
Scientific, Pittsburgh, PA), adjusted to pH 4.15.24 Gel systems produce lesions that are 
histologically comparable to natural lesions.25 The specimens were immersed in the 
demineralizing solution at 37°C for 8 weeks. Specimens were visually examined throughout 
the demineralization process to verify lesion formation and surface integrity of the new-
formed caries-like lesions. After the incubation period, each specimen was cleaned from the 
demineralizing medium, superficially dried with absorbent paper, and observed under a 
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dissecting microscope (Nikon, Melville, NY). Finally, specimens were placed in fresh 
deionized water (high-purity water) and kept at room temperature.
Experimental groups and Study Design
The four specimens extracted from each of the 35 teeth were randomly assigned to four 
groups (n=35 per group): (1) Control (no treatment); (2) MI Paste (10% CPP-ACP crème, 
MI Paste, GC America, Alsip, IL); (3) F5000 (1.1% NaF dentifrice, 5000 ppm, ControlRx, 
3M ESPE, St. Paul, MN), or (4) MI Paste Plus (10% CPP-ACP plus 900 ppm fluoride 
crème, MI Paste Plus, GC America, Alsip, IL). The formulations of each product are 
described in Table 1. Computer-aided randomization was used in a manner that each 
specimen from the same tooth was distributed to one of the four different groups, akin to a 
split-plot design with each tooth constituting a plot. For the treatment phase of the 
experiment, each product was strictly applied using their respective manufacturers’ 
directions (Table 2), daily, for a period ranging from 10 to 30 days. Since amount of product 
for each treatment was limited, one third of the specimens for each treatment group were 
removed after 10 days of follow-up, with an additional one third removed after 20 days 
(exact numbers for each treatment at each time point are given in Table 3). This design 
allowed for the maximum amount of information at the early time points while still retaining 
sufficient sample size for later time points. The applications were performed once in the 
morning and again in the evening. The products were applied in the form of slurry, formed 
by one part of the product and three parts of artificial saliva, directly over the lesions as 
previously published.15 The artificial saliva consisted of 2.2 g/L gastric mucin, 0.381 g/L 
NaCl, 0.231 g/L CaCl2, 0.738 g/L KH2PO4, 1.114 g/L KCl, 0.02% sodium azide, and trace 
of NaOH to pH 7.0.26 Five liters of artificial saliva were freshly prepared on a daily basis. 
One liter was always removed to produce the slurries. The remaining 4 liters were equally 
divided among 4 containers, one for each group. Specimens from the same group were 
collectively stored in the same container. Once the treatment was completed, the specimens 
were rinsed in deionized water for 5 seconds to remove the treatment solution. Immediately 
after the morning treatment, all specimens were submitted to pH cycling, as described 
below. Before the evening treatment, all specimens were placed back in their own artificial 
saliva container for 10 minutes.
pH-cycling
Standard pH-cycling conditions were used in a daily schedule of 3 cycles, each of 30 
minutes of demineralization and 2.5 hours of remineralization27, followed by an “overnight” 
period of 6 hours in artificial saliva. Four liters of each pH-cycling solution were placed in 
different containers, which were also labeled accordingly. The deionized water was placed in 
a third container. Specimens underwent pH-cycling together. Before and between each 
remineralization-demineralization period, the specimens were thoroughly rinsed with 
deionized water. The pH of the artificial saliva was checked daily and the solution replaced 
weekly. Each group had its own container of artificial saliva to avoid any type of 
contamination by other treatment solutions. The remineralization solutions contained 1.5 
mM CaCl2, 0.9 mM KH2PO4, 130 mM KCl, and 20 mM Hepes pH 7.0, and the 
demineralization solution 1.5 mM CaCl2, 0.9 mM KH2PO4, and 50 mM acetic acid adjusted 
to pH 5.0. The pH-cycle solutions were refreshed daily.28
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QLF analysis and outcome measures
Specimen images were acquired using a quantitative light fluorescence (QLF) system, the 
Inspektor QLF System (Inspektor Research System BV, Amsterdam, The Netherlands), 
which comprises a light from a xenon arc lamp with blue filter (λ = 488 nm, 10–20 mW 
cm−2) and camera connected to a computer. Images were captured and analyzed with the 
software provided by the manufacturer (Inspektor™ Pro Software, version 2.0.0.32, 
Amsterdam, The Netherlands). To ensure that images were captured from the same angle 
and in the same camera position, the video-repositioning tool of the software was used 
(correlation set to 0.90). This software holds the baseline image as a reference when trying 
to correlate the subsequent images, based on their similar geometry of the fluorescence 
intensities.29 The importance of this step is to permit a very precise comparison between the 
images captured at different moments in time.30, 31 Additionally, a handmade polyvinyl 
siloxane (Express STD, 3M ESPE) matrix was fabricated to help standardize the position of 
the camera over the specimen. Specimens were kept hydrated in deionized water until 
immediately before analysis. For the image capturing process, each lesion was dried for 5 
seconds with an air syringe and the image was acquired under completely darkened 
laboratory conditions.
The effect of the remineralization protocols on the WSL were quantified by mean 
fluorescence loss (ΔF in %), and the corresponding lesion area (mm2). Images were 
analyzed using the Inspektor™ Pro Software. Identification and delimitation of each lesion 
on the software were done manually. The visual identification of the lesion is made easy 
because the demineralized tissue appears as a dark area surrounded by bright green 
fluorescing sound tissue.32 To delimitate the lesion, a patch is drawn around each dark area 
with its borders in sound enamel.31 The software then virtually reconstructs the fluorescence 
levels of the lesion using the fluorescence radiance of the surrounding sound enamel as 
reference.31 Pixels inside the patch were considered part of the lesion when the relative 
fluorescence loss exceeded 5% threshold.33 Fluorescence loss is the difference in percentage 
between the intensity of the green fluorescence of the sound enamel (high) and the lesion 
(low). The corresponding lesion area is calculated based on the patch borders determined by 
the software. The analyses patch and the surface contours used in the baseline image are 
copied by the software for all the consequential images.
The images were captured after the lesions were created (baseline) and every 10 days until 
the last day of treatment (Figure 1) for a total of 2 to 4 images for each specimen, depending 
on the treatment group. Specimens removed from the groups for analysis did not have 
further images captured.
Statistical analysis
The QLF assessments (fluorescence loss and lesion area) were analyzed using a hierarchical 
mixed effects model. Since interest was in assessing improvement from baseline, the 
outcome in each case was the difference between the follow-up (days 10, 20, and 30) and 
baseline values. To account for the repeated measurements on each specimen a random 
effect for tooth and a random effect for specimen nested within tooth was incorporated. The 
fixed effects in the model included treatment, time, and the treatment*time interaction. 
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Contrasts for differences between treatment groups at each follow-up time point were 
estimated based on the model, along with 95% confidence intervals for the differences. P-
values were adjusted for multiple comparisons to control the false-discovery rate using the 
method of Benjamini and Yekutieli, which controls for multiple dependent hypothesis 
tests.34 Level of significance for both analyses was set at 0.05. The random effects models 
were fit using the lme package with R version 3.0.3.35, 36
RESULTS
Summary statistics (mean, standard deviation (σ), and sample size (n)) for both fluorescence 
loss and lesion area are given in Table 3 for each treatment group at each follow-up time 
point. Figures 2 and 3 give corresponding plots of the mean fluorescence loss and mean 
lesion area, respectively, with vertical bars indicating +/− two standard errors 
to give a rough approximation of a 95% confidence interval for the mean.
Analysis of difference from baseline for fluorescence loss data using a hierarchical mixed 
effects model indicated that the pattern of change in fluorescence loss was not the same for 
the four groups (significant treatment * time interaction: p<0.0001, see Figure 4). Hence, 
treatment comparisons were conducted separately at each follow-up time point. Table 4 
displays the estimated difference between treatment groups at each time point, along with 
95% confidence intervals for the difference and adjusted p-values. The F5000 treatment 
group showed rapid change by day 10 compared to all other groups (F5000 versus Control: 
adjusted p=0.02, MI Paste: adjusted p=0.02, MI Paste Plus: adjusted p=0.01). Differences 
between F5000 and MI Paste remained significant at days 20 and 30, while differences 
between F5000 and MI Paste Plus were significant at day 20 and only marginally significant 
at day 30 (adjusted p=0.08). Differences between F5000 and Control were only marginally 
significant at day 20 (adjusted p=0.08) and non-significant at day 30. The Control group 
showed some improvement relative to MI Paste and MI Paste Plus at day 30, though this 
difference was not statistically significant after adjustment for multiple comparisons (MI 
Paste: adjusted p=0.11, MI Paste Plus: adjusted p=0.29). The Control group was not 
different statistically from either MI Paste or MI Paste Plus on days 10 and 20. No 
statistically significant differences were found between MI Paste and MI Paste Plus at any of 
the follow-up time points.
The results for lesion area are presented in Table 5 and Figure 5. The pattern of change was 
again significantly different for the four groups (treatment * time interaction p<0.0001). The 
F5000 treatment group again presented rapid change at day 10 compared to all other groups 
(Control: adjusted p<0.001, MI Paste: adjusted p<0.001, MI Paste Plus: adjusted p<0.001). 
This difference remained statistically significant across days 20 and 30 as well (adjusted 
p<0.001 in nearly all cases). MI Paste Plus did not differ significantly from MI Paste at day 
10, but did exhibit significant improvement relative to MI Paste at days 20 (adjusted 
p=0.008) and 30 (adjusted p=0.008). In contrast, while MI Paste Plus was significantly 
better relative to Control on days 10 (adjusted p=0.04) and 20 (adjusted p=0.05), this 
improvement was not evident on day 30. The MI Paste group did not differ significantly 
from the Control group on days 10 and 20, however the Control group was significantly 
better than MI Paste on day 30 (adjusted p=0.001).
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In this laboratory study, the methodologies used to quantify remineralization indicated that 
the fluoride group provides greater remineralizing effect over time as compared with the 
Control and the other treatment groups. Although we could not find other studies in the 
literature with strictly comparable methodology, it is reasonable to state that our findings are 
in agreement with those of Pulido and colleagues.15
The efficacy of fluoride as a remineralizing agent is well described in the literature although 
discussion about the relationship between dosage and effect persists.37 Presumably, the high 
concentration fluoride product used in this study (F5000) promotes some degree of 
remineralization over the period of 30 days. Indeed, this was first observed on the 10th day. 
The F5000 had its most pronounced effect during the first 10 days, with a rapid rate of 
remineralization that tended to plateau after that. This was observed for both outcomes. Such 
behavior was expected since it had been described before. Topical application of a high-
concentration fluoride solution presented higher initial rates of mineral deposition, but lower 
subsequently. It was then hypothesized that a fluoride-enhanced deposition occurred 
primarily in the surface layer of the lesion, leading to blocking of the surface layer pores.38 
Another study done using a computer simulation model concluded that lesions cannot be 
repaired by more than 80% of the mineral originally removed due to the surface layer being 
fully remineralized.39 More recently, these previous findings have been challenged. Elevated 
fluoride treatments (5000 ppm) were shown to give increased remineralization when 
compared with traditional fluoride products (1500 ppm) in subsurface lesions, using pH-
cycling model.37 The authors explained the extended fluoride dose-response correlating 
fluoride deposition with lesion depth, pointing out that a fluoride diffusion would be 
responsible for driving fluoride deeper into the lesion, whenever the external level of 
fluoride is elevated. Although it is important to mention that the QLF presents greater 
sensitivity to detect surface changes20, that seemed to be the case in our study. Regarding the 
QLF sensitivity to mineral changes, a statistically significant correlation between QLF and 
Tranverse MicroRadiography (TMR), which is the gold-standard technique for quantifying 
mineral changes of early carious lesions in vitro, has been previously shown.20, 40
Similar remineralizing patterns were also observed for MI Paste and MI Paste Plus groups. 
At some point over the 30 days study period, all the treatment groups appeared to reach a 
turning point where the pace of the remineralization slowed down or stopped. This was 
especially true for the lesion area outcome, but less marked for fluorescence loss. The 
exception to this was the Control group, which exhibited a continuous and also effective 
remineralizing action for fluorescence loss, being exposed only to low concentrations of 
calcium and phosphate. The effect of calcium ion concentration on the remineralization 
process has been studied before. A solution with high calcium content is believed to rapidly 
precipitate ions on the superficial zones of the lesion, preventing the remineralization 
process from occurring in the body of the lesion.41, 42. In the MI Paste and MI Paste Plus 
groups, the presence of CPP in those products would inherently prevent rapid precipitation 
of calcium and phosphate. Indeed, this is the primary action of CPP. It stabilizes clusters of 
calcium, phosphate, and hydroxide ions at high concentrations as amorphous nanocomplexes 
(amorphous calcium phosphate, CPP-ACP), preventing spontaneous phase 
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transformations.43 The same phenomenon can be observed with calcium, phosphate, and 
fluoride (amorphous calcium fluoride phosphate, CPP-ACFP).44 Neutral ions HF0 and 
CaHPO40 are then localized at the tooth surface, allowing the diffusion of these ions deep 
into the lesion and enabling remineralization to occur throughout the body of the lesion.45 
That may help to explain the slower and attenuated remineralization patterns, when 
compared to F5000, observed in these groups for fluorescence loss. Additionally, the low 
concentration of calcium and phosphate in the pH-balanced artificial saliva were probably 
not enough to provoke rapid precipitation either.
Interestingly, both CPP-ACP products, MI Paste and MI Paste Plus, presented similar or 
even lower performances for mean fluorescence loss and lesion area when compared with 
the Control group. For this observation, several important factors may have played a role. 
Since the pH-balanced artificial saliva formulation purposely contained CaCl2 and KH2PO4, 
to better reproduce the oral environment, a certain degree of remineralization caused by 
exposure of the groups to this solution occurred. This potential remineralizing effect has 
been observed both in vitro and in vivo, causing regression of carious lesions.15, 31, 46 In 
fact, the effect of CPP-ACP on enamel surface has been previously shown to be similar to 
the remineralizing effect of saliva.47 Yet, the formation of a biofilm as seen in vivo, and its 
potential to directly influence the ionic changes in the oral environment are very difficult to 
recapitulate with an artificial saliva substitute48, leading to a second consideration. The lack 
of biofilm and, consequently, the optimal environment for the CPP-ACP to create a state of 
supersaturation of calcium and phosphate ions could have prevented this system from 
properly exerting a remineralizing action of these products.
In light of the issue stated above, it is logical to postulate that due to the lack of a biofilm, all 
products tested were completely washed away by the deionized water immediately after the 
treatment times were completed. As a result, the treatment times may have been too short to 
provide substantial remineralizing benefits. The treatment exposure time was applied 
following the manufacturer’s directions and should therefore reflect the exposure that would 
occur clinically. Despite the acid challenge that specimens were subjected to after the 
treatments were completed, the acidic activation of CPP-ACP molecules separating ACP 
from casein, as previously suggested49, was very unlikely because of the absence of material 
on the tooth surface, i.e. biofilm. If this is true, the ACP would not precipitate and, 
consequently, promote crystal growth. Then, the remineralization would come primarily 
from the artificial saliva.
Does the addition of fluoride to CPP-ACP enhance its remineralizing capacity? The outcome 
measures for MI Paste Plus compared to MI Paste group indicates that the addition of 
fluoride does enhance remineralization. Based on mean fluorescence loss, the F5000 group 
showed improved remineralization relative to MI Paste Plus group, but did not differ 
statistically from the Control group at the end of 30 days.
CONCLUSIONS
Based on the findings of this study and within its limitations, we conclude that 1.1% NaF 
dentifrice demonstrated greater remineralization ability than 10% CPP-ACP topical tooth 
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crème. When compared to the fluoride-containing 10% CPP-ACP Plus, the QLF analysis 
also demonstrated a greater remineralization ability of the 1.1% NaF dentifrice for the 
outcome mean lesion area. However, the 1.1% NaF dentifrice was only as effective as the 
Control to reduce fluorescence loss at the end of the 30 days period. Saliva also has the 
ability to exert an important remineralization effect over time. Moreover, the period of 10 
days may be enough to remineralize white spot lesions in vitro when a dentifrice containing 
1.1% NaF (5000 ppm) is used as therapeutic agent. The addition of fluoride to 10% CPP-
ACP seems to enhance its remineralization ability based on our fluorescence loss studies.
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This study showed that a 1.1% NaF dentifrice (5000 ppm) demonstrated greater 
remineralization ability than the CPP-ACP topical tooth crème and that the addition of 
fluoride to its formulation seems to enhance remineralization. Saliva also has the ability 
to exert an important remineralization effect over time.
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QLF screen image representing the analysis process of the circumscripted white spot lesion 
at baseline and after treatment was applied overtime*
* Note the yellow color on the body of the lesion denoting area of higher scattering of light 
and, consequently, more demineralized tissue. On the second image, note the purple tone in 
the body of the lesion indicating less scattering of light and, consequently, a more 
remineralized tissue. In addition, the lesion area is slightly reduced, especially on the 
borders of the lesion.
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Mean fluorescence loss by treatment group and time. Vertical bars indicate +/− two standard 
errors  and give a rough approximation of a 95% confidence interval for the 
mean. Points are slightly staggered at each time point for better visualization of the vertical 
bars.
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Mean lesion area by treatment group and time. Vertical bars indicate +/− two standard errors 
 and give a rough approximation of a 95% confidence interval for the mean. 
Points are slightly staggered at each time point for better visualization of the vertical bars.
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Model predicted estimates of the mean difference in fluorescence loss from baseline, for 
each treatment group at each follow-up time point. Estimates were based on the hierarchical 
random effects model with random effects for tooth and specimen nested within tooth and 
fixed effects for treatment, time, and treatment*time interaction. Vertical bars indicate model 
based estimates of 95% confidence intervals for the mean difference from baseline. Points 
are slightly staggered at each time point for better visualization of the vertical bars.
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Model predicted estimates of the mean difference in lesion area from baseline, for each 
treatment group at each follow-up time point. Estimates were based on the hierarchical 
random effects model with random effects for tooth and specimen nested within tooth and 
fixed effects for treatment, time, and treatment*time interaction. Vertical bars indicate model 
based estimates of 95% confidence intervals for the mean difference from baseline. Points 
are slightly staggered at each time point for better visualization of the vertical bars.
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Table 1
Products tested and respective compositions.
Product Composition
ControlRX Sodium Fluoride 1.1% w/w, water, Sorbitol, Hydrated Silica, Glycerin, MICRODENT® 2.0% w/v – a patented 
ULTRAMULSION® of Dimethicone and Poloxamer 407, PEG 12, Flavor, Cellulose Gum, Sodium Lauryl Sulfate, Titanium 
Dioxide, Sodium Saccharin
MI Paste Pure water, glycerol, 10% by weight of CPP-ACP, D-sorbitol, CMC-Na, propylene glycol, silicon dioxide, titanium dioxide, 
xylitol, phosphoric acid, flavoring, zinc oxide, sodium saccharin, ethyl p-hydroxybenzoate, magnesium oxide, guar gum, 
propyl p-hydroxybenzoate, butyl p-hydroxybenzoate
MI Paste Plus Pure water, glycerol, 10% by weight of CPP-ACP, d-sorbitol, CMC-Na, propylene glycol, silicon dioxide, titanium dioxide, 
xylitol, phosphoric acid, sodium fluoride, flavoring, sodium saccharin, ethyl p-hydroxybenzoate, propyl p-hydroxybenzoate, 
butyl p-hydroxybenzoate
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Table 2
Products tested and correspondent application procedures
Product Directions for use
ControlRx Applied once every 12 hours, in a form of slurry, made with 1 part of toothpaste to 3 parts of artificial saliva. Product was 
applied for 2 minutes and rinsed with deionized water for 5 seconds.
MI Paste Applied once every 12 hours, in a form of slurry, made with 1 part of toothpaste to 3 parts of artificial saliva. Product was 
applied for 3 minutes and rinsed with deionized water for 5 seconds. No application of fluoride was done prior to this 
treatment.
MI Paste Plus Applied once every 12 hours, in a form of slurry, made with 1 part of toothpaste to 3 parts of artificial saliva. Product was 
applied for 3 minutes and rinsed with deionized water for 5 seconds.
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Table 3
Summary statistics for fluorescence loss and lesion area for each treatment group at baseline and each follow-
up time point. Entries in each cell are mean, standard deviation (σ), and sample size (n).
Fluorescence Loss Baseline Day 10 Day 20 Day 30
Control −12.77 (5.42) (n=35) −11.55 (2.58) (n=35) −10.02 (2.24) (n=25) −8.38 (1.40) (n=11)
F5000 −13.36 (6.55) (n=35) −8.10 (3.00) (n=35) −7.98 (3.27) (n=23) −7.81 (2.15) (n=11)
MI Paste Plus −11.01 (3.52) (n=35) −10.11 (2.61) (n=35) −9.27 (2.57) (n=22) −8.92 (1.23) (n=11)
MI Paste −12.09 (4.83) (n=34) −10.8 (3.01) (n=34) −10.86 (2.86) (n=22) −10.23 (2.31) (n=11)
Lesion Area
Control 7.03 (1.90) (n=35) 3.71 (2.04) (n=35) 2.89 (1.71) (n=25) 2.07 (1.83) (n=11)
F5000 7.45 (2.04) (n=35) 0.85 (1.01) (n=35) 0.80 (1.08) (n=23) 0.70 (0.98) (n=11)
MI Paste Plus 7.43 (2.11) (n=35) 2.90 (1.67) (n=35) 2.06 (1.42) (n=22) 2.27 (1.12) (n=11)
MI Paste 6.70 (2.10) (n=34) 3.04 (2.18) (n=34) 3.21 (2.19) (n=21) 3.23 (2.27) (n=10)
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